Merck & Co
The Latest
-
Merck Finally Joining Global Race To Develop Covid-19 Vaccine
Apart from acquiring Austrian vaccine maker Themis Bioscience, Merck is also working with a number of other medical firms to develop separate coronavirus vaccines. 
Apart from acquiring Austrian vaccine maker Themis Bioscience, Merck is also working with a number of other medical firms to develop separate coronavirus vaccines. -
Merck Expects $2.1 Billion Sales Hit From Coronavirus Pandemic
Merck expects a huge hit on its sales this year given that more than two-thirds of its products need to be administered by doctors. 
Merck expects a huge hit on its sales this year given that more than two-thirds of its products need to be administered by doctors. -
Merck To Spin-Off Businesses To Focus More On Growth Drivers
Merck & Co will be spinning off its other businesses, including its women's health and biosimilar drug units, into separate publicly-listed companies. 
Merck & Co will be spinning off its other businesses, including its women's health and biosimilar drug units, into separate publicly-listed companies. -
Merck Acquires Cancer Drug Maker Peloton For $2.2 Billion
Merck & Co agreed to pay the cancer drug manufacturer $1.05 billion in cash and $1.15 billion in additional payments. 
Merck & Co agreed to pay the cancer drug manufacturer $1.05 billion in cash and $1.15 billion in additional payments.
